These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10155257)

  • 1. New antithrombotic drugs for systemic and local delivery for coronary artery disease.
    Shah PK
    J Interv Cardiol; 1995 Aug; 8(4):427-37. PubMed ID: 10155257
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy in acute coronary syndromes.
    Watson RD; Chin BS; Lip GY
    BMJ; 2002 Dec; 325(7376):1348-51. PubMed ID: 12468488
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithrombotic agents in coronary artery disease.
    Cairns JA; Lewis HD; Meade TW; Sutton GC; Théroux P
    Chest; 1995 Oct; 108(4 Suppl):380S-400S. PubMed ID: 7555191
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic therapy in acute coronary syndromes.
    Sabatine MS; Jang IK
    Acta Cardiol; 1999 Feb; 54(1):3-29. PubMed ID: 10214473
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW; Sutton GC
    Chest; 1998 Nov; 114(5 Suppl):611S-633S. PubMed ID: 9822067
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antithrombotic therapy in chronic coronary syndromes--value of thrombocyte aggregation inhibition, anticoagulation and chronic thrombolysis].
    Leschke M; Schoebel FC; Stiegler H; Fischer Y; Schannwell CM; Strauer BE
    Z Kardiol; 1998; 87 Suppl 2():145-51. PubMed ID: 9827473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mode of action and clinical applications of phosphodiesterase inhibitors as anti-platelet drugs].
    Murohara Y; Takatsu Y; Yui Y; Kawai C
    Nihon Rinsho; 1989 Apr; 47(4):935-9. PubMed ID: 2545947
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions.
    Connolly DL; Lip GY; Chin BS
    BMJ; 2002 Dec; 325(7377):1404-7. PubMed ID: 12480860
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotic therapy in patients with combined coronary heart disease and atrial fibrillation.
    Thompson PL; Morton AC
    Panminerva Med; 2016 Mar; 58(1):23-33. PubMed ID: 26658287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic agents in coronary artery disease.
    Cairns JA; Théroux P; Lewis HD; Ezekowitz M; Meade TW
    Chest; 2001 Jan; 119(1 Suppl):228S-252S. PubMed ID: 11157652
    [No Abstract]   [Full Text] [Related]  

  • 11. In search of a superaspirin for the heart.
    Verheugt FW
    Lancet; 1997 May; 349(9063):1409-10. PubMed ID: 9164311
    [No Abstract]   [Full Text] [Related]  

  • 12. Future directions in thrombolysis.
    Willerson JT; Zoldhelyi P
    Clin Cardiol; 1999 Aug; 22(8 Suppl):IV44-53. PubMed ID: 10492853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombosis therapy in ischemic heart disease].
    Cerveró Martí A; Echánove Errazquin I; Noguera Sanchis R
    Med Clin (Barc); 1988 Apr; 90(16):670-4. PubMed ID: 3294537
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary thrombolysis.
    de Bono D
    Br Heart J; 1987 Apr; 57(4):301-5. PubMed ID: 3555565
    [No Abstract]   [Full Text] [Related]  

  • 16. [An antithrombotic therapy from the viewpoint of hematology].
    Asakura H
    Brain Nerve; 2015 Jan; 67(1):83-91. PubMed ID: 25585437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Path of exploration for the optimal antithrombotic treatment strategy for patients with coronary heart disease].
    Li Y; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):429-431. PubMed ID: 35589590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current problems of antithrombotic therapy].
    Liusov VA; Belousov IuB
    Kardiologiia; 1981 Aug; 21(8):5-17. PubMed ID: 7026869
    [No Abstract]   [Full Text] [Related]  

  • 19. [Advances and perspectives of antithrombotic therapy for coronary artery diseases in China].
    Li Y; Zhao R; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Sep; 47(9):683-688. PubMed ID: 31550834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
    Zhao XQ; Théroux P; Snapinn SM; Sax FL
    Circulation; 1999 Oct; 100(15):1609-15. PubMed ID: 10517731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.